Validation of enantioseparation and quantitation of an active metabolite of abrocitinib in human plasma

Effects of Hepatic Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites

(2021) Ellen Q. Wang et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

(2021) Thomas Bieber et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

(2020) Eric L Simpson et al.   LANCET

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis

(2020) Jonathan I. Silverberg et al.   JAMA Dermatology

Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis

(2019) Melinda J. Gooderham et al.   JAMA Dermatology

Review: Recent Application of Chiral Liquid Chromatography-Tandem Mass Spectrometric Methods for Enantiomeric Pharmaceutical and Biomedical Determinations

(2013) Y. Nie et al.   JOURNAL OF CHROMATOGRAPHIC SCIENCE

Chiral Separations: Fundamental Review 2010

(2010) Timothy J. Ward et al.   ANALYTICAL CHEMISTRY

Pharmacologically active compounds in the environment and their chirality

(2010) Barbara Kasprzyk-Hordern   CHEMICAL SOCIETY REVIEWS

Present State of New Chiral Drug Development and Review in Japan

(2008) Rumiko Shimazawa et al.   JOURNAL OF HEALTH SCIENCE